COMP <GO>
INGR vs CPB // RSI-14 & 200D SMA MOMENTUM
Ingredion Incorporated (NYSE) VS. The Campbell's Company (NASDAQ) • 15-METRIC TALLY: INGR 7
— CPB 6
▲ RSI-14 & 200D SMA MOMENTUM LEADER: CPB
LAST: $95.59 (+1.42%) • MKT CAP: $6.03B
rsi-technicals
45.9
LAST: $21.00 (+1.99%) • MKT CAP: $6.26B
rsi-technicals
56.1
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INGR VS. CPB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INGR | CPB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 25.30% | 30.40% | -5.10 | CPB | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.10% | 10.80% | +5.30 | INGR | /roic <GO> |
| EV/EBITDA & P/E Valuation | 4.9x | 7.0x | -2.10 | INGR | /valuation <GO> |
| Free Cash Flow Yield | 8.48% | 11.26% | -2.78 | CPB | /fcf-yield <GO> |
| Operating Margin | 14.10% | 11.00% | +3.10 | INGR | /operating-margins <GO> |
| Net Profit Margin | 10.10% | 5.90% | +4.20 | INGR | /net-margins <GO> |
| Revenue Growth (YoY) | -2.80% | 6.40% | -9.20 | CPB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.50% | 7.33% | -3.83 | CPB | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.69 | 1.68 | +2.01 | INGR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 45.9 | 56.1 | -10.20 | CPB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.16 | 0.99 | +0.17 | INGR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 7.7x | 9.7x | -2.00 | INGR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.03B | $6.26B | -$234.6M | CPB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INGR REV | CPB REV | INGR GROSS % | CPB GROSS % | INGR FCF | CPB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.22B | $10.25B | 25.3% | 30.4% | $511.0M | $705.0M |
| FY 2024 | $7.43B | $9.64B | 24.1% | 30.8% | $1.14B | $668.0M |
| FY 2023 | $8.16B | $9.36B | — | — | $689.8M | $721.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INGR // BETA 1.16
CPB // BETA 0.99